Recombinant human tissue-type plasminogen activator is an effective agent for thrombolysis of peripheral arteries and bypass grafts: Preliminary report
- 30 November 1989
- journal article
- Published by Elsevier in Journal of Vascular Surgery
- Vol. 10 (5) , 491-500
- https://doi.org/10.1016/0741-5214(89)90130-4
Abstract
No abstract availableThis publication has 33 references indexed in Scilit:
- Thrombolytic Therapy: Current StatusNew England Journal of Medicine, 1988
- Thrombolysis of peripheral arterial bypass grafts: Surgical thrombectomy compared with thrombolysisJournal of Vascular Surgery, 1988
- Thrombolytic TherapyAnnual Review of Medicine, 1988
- Thrombolytic therapy with recombinant human tissue-type plasminogen activator: a comparison of two doses.Radiology, 1987
- Recombinant human tissue-type plasminogen activator for thrombolysis in peripheral arteries and bypass grafts.Radiology, 1986
- Peripheral artery and bypass graft thrombolysis with recombinant human tissue-type plasminogen activatorJournal of Vascular Surgery, 1986
- Cloning and expression of human tissue-type plasminogen activator cDNA in E. coliNature, 1983
- Purification and partial characterization of plasminogen activator from human uterine tissueBiochimica et Biophysica Acta (BBA) - Protein Structure, 1979
- Outcome of Recent Thromboembolic Occlusions of Limb Arteries Treated with StreptokinaseBMJ, 1970
- THE MAINTENANCE OF A SUSTAINED THROMBOLYTIC STATE IN MAN. I. INDUCTION AND EFFECTS*Journal of Clinical Investigation, 1959